Osaic Holdings
CLYM

Osaic Holdings’s Climb Bio CLYM Stock Holding History

Osaic Holdings’s Portfolio CLYM Stock Details CLYM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$23.3K Buy
3,400
+2,800
+467% +$16.2K ﹤0.01% 5756
2025
Q4 		$2.4K Sell
600
-22,000
-97% -$52.8K ﹤0.01% 7027
2025
Q3 		$45.1K Buy
22,600
+22,305
+7,561% +$41.4K ﹤0.01% 5376
2025
Q2 		$360 Buy
+295
New +$367 ﹤0.01% 7407
2024
Q4 		– Sell
-8,333
Closed -$21.7K – 7689
2024
Q3 		$21.7K Hold
8,333
– – ﹤0.01% 5341
2024
Q2 		$21.7K Hold
8,333
– – ﹤0.01% 5290
2024
Q1 		$21.7K Hold
8,333
– – ﹤0.01% 5313
2023
Q4 		$22.5K Hold
8,333
– – ﹤0.01% 5435
2023
Q3 		$21.9K Hold
8,333
– – ﹤0.01% 5505
2023
Q2 		$23.3K Buy
+8,333
New +$25.3K ﹤0.01% 5463

Other funds holding CLYM

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return